JAKARTA - Spokesperson for the Task Force (Task Force) Handling COVID-19 Wiku Adisasmito said the public does not need to worry about the safety of vaccines to fight the virus. Because, in the process of procuring the COVID-19 vaccine, the Food and Drug Supervisory Agency (BPOM) is guarding it.
BPOM will be involved from evaluating the vaccine protocol to inspection of its administration to ensure the safety and effectiveness of the COVID-19 vaccine is achieved.
"Apart from that, requirements for product quality, vaccine product facilities and product completion are also considered," said Wiku in a press conference broadcast on the YouTube account of the Presidential Secretariat, Thursday, October 15.
He asked the public to believe in this COVID-19 vaccine. Because, in the third phase of clinical trials that are being carried out, no volunteers have experienced side effects.
"There have been no reports from clinical trial volunteers," he said.
Wiku said the vaccination scheme was being prepared by the government, especially the Ministry of Health.
"It is hoped that this road map can be completed and become concrete steps to be conveyed in the vaccine program. Vaccination is carried out based on the level of risk the community has," he said.
"All details of vaccination are in the finalization stage and will consider the criteria and priorities for recipients in the Presidential Decree," he added.
Currently, there are several types of vaccines prepared by the government, including Sinopharm, Cansino, and Astrazeneca. However, the vaccine will undergo stages whose function is to ensure its safety for humans.
Thus, he asked the public not to easily believe in false information regarding vaccines.
"In the midst of the swift flow of information about vaccines, we need to instill a smart and selective attitude in receiving messages, before believing and deciding to share this information with others," he concluded.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)
أخبار ذات صلة
